Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Palleon Pharmaceuticals
4025
Palleon Pharmaceuticals
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Palleon is targeting glycan-sensing checkpoints to unleash both the innate and adaptive immune responses to cancer.
Suggest edits
Raised
$48M
Follow us
Companies in the same industry
Camallergy
Labii Inc.
Bioquark Inc.
Oculis
Hyasynth Bio
Viventia Bio Inc.
Athersys Inc
Haoma Medica Ltd.
Spiral Therapeutics
Aratana Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$48,000,000
Venture capital (Series A) - 2017
SR One
AbbVie Biotech Ventures
Pfizer Venture Investments
+5
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$48,000,000
Venture capital (Series A)
Xconomy
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug
Health
Science
Funding
